Mergers, acquisitions and investments are risky endeavors and it is impossible for an investor or acquirer to know everything before committing.
Health Business Group helps to validate investment hypotheses and improve clarity about a company’s prospects through commercial due diligence. We interview the target’s customers and competitors, consult with regulatory experts and industry observers, analyze secondary data sources, and leverage our extensive internal knowledge base.
Most importantly, we focus specifically on what our clients need to know before they write a significant check. And we are not afraid to speak up and advise that a deal does not make sense if that’s what we believe, even when that’s not what our client wants to hear.
Our teams are experienced and flexible, and because of our mix of long-term projects and retained relationships we are able to provide surge capacity when short turnaround diligence assignments arise. We turn down assignments when we are over committed, but usually we are able to put a high-caliber diligence team together on short notice to meet tight deadlines.
|
Due Diligence
Temperature-Controlled Packaging: From Diligence Insight to Market Expansion Validated market growth, competitive positioning, and regulatory risk for a PE investor considering acquiring a reusable temperature-controlled packaging supplier. Read more → |
Due Diligence
CDMO Due Diligence: Pinpointing Opportunity in a Complex Market Validated market attractiveness, customer stickiness, and management strength for an investor acquiring a fast-growing contract development and manufacturing organization. Read more → |
|
|
Due Diligence
CCM/RPM Diligence: Testing Investment Thesis Under Regulatory Uncertainty Helped an investor assess reimbursement and policy risk for a chronic care management and remote monitoring acquisition before bidding. Read more → |
Due Diligence
Temperature-Controlled Packaging: Positioning for a Successful Exit Produced an independent market study to educate buyers and strengthen the sale narrative for a PE-sponsored TCP company navigating post-pandemic market volatility. Read more → |
|
|
Due Diligence
Contract Development and Manufacturing Organization (CDMO) for Aseptic Products Provided commercial due diligence for a real estate investor evaluating a fast-growing CDMO, covering industry demand, competitive dynamics, and customer relationships. Read more → |
||